A Pragmatic Approach Towards The Regulation of Botanical Food Supplements

Similar documents
WORKABLE REGULATORY FRAMEWORK EUROPEAN PARLIAMENT, BRUSSELS 9 NOVEMBER 2016

ehpm Discussion Paper on Botanical Health Claims

ROADMAP TO REVIEW THE NUTRITION AND HEALTH CLAIMS REGULATION 1924/2006 Food Supplements Europe Comments

Botanicals and botanical preparations in the EU: evolution through time towards full harmonisation. Opportunities and challenges.

Regulatory aspects of Herbal Medicinal Products. and Supplements in EU / the Netherlands. Ir. Theo van Rooij

Roadmap to review the Nutrition and Health Claims legislation expression of interest to contribute to the upcoming external study

Health Claims and Botanicals: How to Proceed with European Harmonisation?

15 years of the European Union s Food Supplement Directive

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Recent Developments in Regulation of Nutrition and Health Claims

PRODUCT INGREDIENT RELATED HEALTH CLAIMS ASSESSMENT for NU SKIN PHARMANEX PRODUCTS in EUROPE

Assessing the Suitability of Application of Traditional Clinical Trial to Food

FSE s approach to novel foods BELFRIT List

Industry and globalisation of herbal medicines

Using science to establish effective food safety control for the European Union Dr David Jukes

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)

Herbal products: Marketing strategies and legislation

The Nutrition and Health Claims Regulation

Regulatory framework

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 25 June 2007

EUROPEAN COMMISSION. Modus Operandi for the management of new food safety incidents with a potential for extension involving a chemical substance

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

analyze & realize GmbH

Nutrient profiles for foods bearing claims

Ornsurang Teerawat

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 13 JUNE 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

N. BUNYAPRAPHATSARA. ASEAN Harmonization on Traditional Medicine and Health Supplement Registration Requirement

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012

The precarious status of! herbal products in the EU

3 The Regulation of Food Supplements in Europe: How much harmonisation is needed?

BASF Plant Science Amflora Facts. Content

OPPORTUNITIES FOR OMEGA-3 PRODUCTS

authorisation of nutrition & health claims Scientific substantiation of health claims Role of the European Food Safety Authority

PRODUCT INGREDIENT RELATED HEALTH CLAIMS ASSESSMENT for NU SKIN PHARMANEX PRODUCTS in EUROPE

Industry Post-Regulation. E-Cigarette Summit Tim Phillips, ECigIntelligence. 17 th November

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

European Food Safety Authority

COMMISSION REGULATION (EU) No /.. of XXX

WCO Guidelines for the recognition of University Customs Curricula (2018)

Food Legislation. Janet Worrell July 2014

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

The Regulatory Environment in New Zealand. Michelle Palmer Natural Products New Zealand

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

GENERAL PRINCIPLES ON FLEXIBILITY OF WORDING FOR HEALTH CLAIMS

Functional drinks innovation pointers. A Leatherhead Food Research white paper. Jenny Arthur

'SECTION B EU PARTY. The following abbreviations are used:

December 4, 2017 VIA ELECTRONIC SUBMISSION

The Italian approach to probiotics

CFS MYPoW Chair Proposal on the HLPE work in 2018

GP for Ayurveda Medicines in Europe Ing. Cornelis J.M. Peters

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

Federation of EU Specialty Food Ingredients Industries

GLP in the European Union Ecolabel detergents, GLP and accreditation

SAFE ANNUAL CONFERENCE Workshop to identify recommendations for EFSA

TGA: the current regulatory reform agenda

JOINT ANH/BENEFYT POSITION PAPER

Update from the European Commission s Working Group meeting on health claims, 31 March 2015

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 15 July 2009

PUBLIC CONSULTATION DOCUMENT

Tobacco Free Ireland Action Plan

European Medicines Agency COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

Background EVM. FAO/WHO technical workshop on nutrient risk assessment, Geneva, May 2005, published 2006.

Other EU Activities Contributing to Harmonization of Labeling

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

Dutch Life Sciences November 24 th, Erik Dam, CBO

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

CIAA COMMENTS ON DG SANCO DISCUSSION PAPER ON NUTRITIONAL AND FUNCTIONAL CLAIMS

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

Qualified Presumption of Safety (QPS) an EFSA Tool for Microbial Safety Assessment

OHSAS 18001:2007 OCCUPATIONAL HEALTH & SAFETY MANAGEMENT SYSTEM WHITE PAPER Lakshy Management Consultant Pvt Ltd aiming excellence

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

(SECTION ON GENERAL FOOD LAW)

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Market surveillance of medical devices

LEAF Marque Assurance Programme

Plain Packaging and Intellectual Property Rights. Cheng Tan, Head of Trade Marks

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

ASEAN Health Supplements Regulatory Harmonisation Update

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 23 APRIL 2014

The Nutrition (Amendment) (EU Exit) Regulations 2018

Emanuela Turla Scientific Officer Nutrition Unit - EFSA

DIRECTIVE AMENDING FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVE 2001/83/EC

Drug Misuse and Dependence Guidelines on Clinical Management

TECHNICAL REPORT. European Food Safety Authority 2, 3. European Food Safety Authority (EFSA), Parma, Italy

SUBMISSION TGA CONSULTATION: INCENTIVES FOR INNOVATION PROTECTION MECHANISMS FOR EVIDENCE-BASED, PRE-ASSESSED COMPLEMENTARY MEDICINES JUNE 2018

POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT

REGULATORY CHALLENGES IN SOUTH AFRICA

Patient Education at the Point of Dispensing Improves Adherence and Increases Sales

Magyar Nemzeti Szívalapítvány Hungarian National Heart Foundation

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

FoodDrinkEurope Position on GLP studies

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 10 FEBRUARY 2015

Towards Integrated Syndromic Surveillance in Europe?

Type 1 Diabetes Australian Research Impact Analysis

DSQC Overview. Scott Kuzner, Ph.D. USP Global External Affairs Director

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

Guidelines c o n n e c t t o t h e w o r l d o f d a i r y

Transcription:

A Pragmatic Approach Towards The Regulation of Botanical Food Supplements

1. Botanicals 2. Basic Principles 3. Current Situation 4. Safety 1. Quality standards 2. Inventory of the products on the market 3. Ingredients 4. Possible approach 5. Health Claims 6. Conclusion Overview

1. Botanicals Issues linked to food supplements to be addressed? What does the food supplement industry need to thrive? What do consumers need in order to be confident in our products?

2. Basic Principles Consumers need safe, effective and non- misleading products What does this mean? 1. SAFETY: Safe and manufactured to high quality standards products 2. HEALTH CLAIMS: Claimed benefits delivered

3. Current Situation At EU Level: Regulation (EC) No 178/2002 à framework for food safety in general Directive 2002/46/EC à additional safety and labelling rules Regulation (EC) No 1925/2006 à other substances to foods Regulation (EC) No 1924/2006 à health and nutrition claims on labelling

4. Safety 4.1. Quality standard Rapid alert on FS only from imports from third countries (internet sales) Excellent safety record for the European FS industry thanks to national best practice & industry developed standards à A model for harmonization?

4. Safety 4.1. Quality standard Examples of Best Practice EHPM Quality Guide Belgium: sectorial Quality Guide (NAREDI): reference standard for audit by authorities/certified auditors Official licence needed for manufacturing supplements Poland: Self- Regulation system based on EHPM Quality Guide à Possible model: EHPM quality guide base for CEN Standard (European Committee for Standardization)?

4. Safety 4.2. Inventory of products on the market Optional notification system foreseen by Directive 2002/46/EC à applied differently by Member States

4. Safety 4.2. Inventory of products on the market Examples: Some Member States have online systems for notification Some Member States have no notification procedure Belgium: test automated monitoring of internet sales to detect illegal products.

4. Safety 4.3. Ingredients Different systems for safety: positive/negative list case by case assessment Some Examples: 1. BELFRIT List Positive list developed in collaboration between authorities: Belgium, France & Italy, to be implemented into national law in each country 2. Germany: Stoffliste (informal) 3 categories: Not recommended (List A) Permitted with conditions (List B) Under Scrutiny (List C) 3. Some approaches (Belgium, France) include dosage rules that can help address borderline issues etc.

4. Safety 4.4. Possible Approach Regulation (EC) No 1925/2006: lists of substances that can be added to food (permitted, prohibited, under scrutiny) Similar approach legitimate for botanical food supplements? Positive list: plants all MS agree can be used based on safety Negative list: plants all MS agree are unsafe because of safety concerns If no agreement by all MS: Placed on under scrutiny list National rules apply plus Regulation (EC) 764/2008 on mutual recognition until agreement is found

5. Health Claims The assessment of 2,000 botanical health claims is pending It is important to have a system that: Ensure only credible claims are used Is accessible to SMEs One does not exclude the other

5. Health Claims Need for a proportionate evidence based system that takes tradition into account Directive 2004/24/EC on herbal medicines accepts tradition of use as a factor in assessment Why accept tradition as: proof of efficacy for the therapeutic effect of a medicine NOT for the physiological effect of a food? Existing national best practice can provide the answer à many Member States already had functioning systems in place to control the use of health claims

5. Health Claims EFSA s model on clinical trials is not working resulting in reduced investment in innovation Disproportional decision: claims rejected despite trials showing benefits in majority of trial subjects Examples: Prune: bowel maintenance effect claim first rejected then approved following challenge Probiotics: many trials evidenced positive effect but claim still rejected à Rules could be created for different categories of claims to recognise tradition and allow for innovation by SMEs à Need to adapt approach allowing for assessed- tradition based health benefits understood thanks to modern science.

5. Health Claims Industry is not seeking a free for all on botanicals health claims Assessment can include: Identification of the history and tradition of use on the market for a specific health benefit Review of existing recognitions by national authorities High Quality Scientific Assessment based on a comprehensive review of the scientific literature: Study of constituents for active substances; Review of In vitro and In vivo studies into mode of action; Critical Appraisal of Human Studies SMEs should be allowed to innovate

6. Conclusion New regulatory structure must work for consumers, regulators and industry Approach will be crucial for the future growth and development of the food supplement sector A solution may come from existing best practices EHPM will be an active and constructive partner: In developing a pragmatic solution Working for all parties